FDA Approval Activities for this Drug
Uroxatral (alfuzosin hydrochloride) extended release tablets, 10 mg Sanofi-Synthelabo NDA 21-287/S1 7/15/03 7/28/03
Uroxatral (alfuzosin hydrochloride) extended release tablets, 10 mg Sanofi-Synthelabo NDA 21-287
Latest Approvals. More focused than the major search engines
FDA Portal.
|